Shangkehuangshui is a traditional Chinese medicine used for treating injuries. Despite its effectiveness, we still don't know how it works.
UPLC-QTOF-MS/MS identified 42 alkaloid glycosides, including two potentially new compounds, in traditional Chinese medicines. This aids in understanding their chemical composition and isolating alkaloid glycosides in other herbal medicines.
This study separated and purified eight compounds from Phellodendron chinense using different chromatography techniques. The purified compounds include six alkaloids and two phenolic acids. Purity of the compounds was over 95.0%.
A study conducted a comprehensive review to evaluate the effectiveness and safety of heat-clearing and dampness-eliminating Chinese medicine (HDCM) for high-risk cervical HPV-infected patients. This information is important for making informed decisions about treating cervical HPV infections using HDCM.
This study explores the relationship between traditional Chinese herbal medicine (CHM) and the survival rate in breast cancer patients, specifically those diagnosed with stage IV. While CHM has shown promise in improving survival rates and quality of life for metastatic cancer patients, little research has been done on its effects in stage IV breast cancer. This research aims to fill that gap and contribute to the growing field of personalized medicine by examining the association between CHM and survival rates in different stages of breast cancer.
This study explored the potential neuroprotective effects of berberine (BBR) against Alzheimer's disease (AD) in vitro. Researchers established an apoptotic model in HT22 cells induced by Aβ and treated them with BBR. Results showed that BBR improved cell viability, inhibited Aβ-induced apoptosis and intracellular ROS levels, and intensified the activity of Nrf2/HO-1 antioxidants in HT22 cells. It also restrained the mitochondrial pathway of cellular apoptosis by decreasing the rate of p-p65/p65, cytochrome C, and cleaved caspase-3. This led the researchers to conclude that BBR provides neuroprotectiveness by alleviating oxidative stress and inhibiting the mitochondrial pathway of cellular apoptosis.
In this study, researchers analyzed the components of the dried bark of Phellodendron chinense and found it contains phellodendrine and berberine. They tested these components for their potential use in treating Alzheimer's disease and found they both inhibited the activity of acetylcholinesterase, an enzyme involved in the disease. Additionally, the bark extract and phellodendrine had antioxidant properties and protected brain cells from oxidative damage. While neither component had an effect on the beta-amyloid protein associated with Alzheimer's, this research suggests that Phellodendron chinense has potential as an anti-Alzheimer's agent.